BridgeMD
New treatment option for Persistent Post-concussive Symptoms
Official title Transcutaneous Auricular Vagus Nerve Stimulation for Persistent Post-concussion Symptoms
ClinicalTrials.gov ID: NCT07017257
What this study is testing
- What it's testing
- Persistent post-concussive symptoms (PPCS) affect a significant proportion of individuals following a concussion, leading to debilitating impacts on their quality of life and work capacity. Currently, effective treatments for PPCS are limited, despite their lasting and debilitating impact.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 65
You may be able to join if
- Age between 18 and 65;
- Between 4 weeks and 1-year post-diagnosis of a concussion;
- Score equal or above 16 on the Rivermead Post-Concussion Questionnaire;
- Intact skin at the electrode site.
You likely can't join if
- History of chronic neurological or psychological disorders (still untreated 6 months preceding inclusion);
- Pregnancy or breastfeeding;
- Presence of an active implant (e.g., pacemaker, cochlear implant);
- History of myocardial infarction or cardiac arrhythmia;
- Excessive alcohol consumption (\> 14 drinks per week) and/or drug (\> 1x/week) use within the past 6 months.
The study team makes the final eligibility decision.
Where it's taking place
- Liège, Liège, Belgium
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 65 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Liège, Liège, Belgium. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.